0 188

Cited 0 times in

Interim Results of the Phase 1 Study of Tnb-486, a Novel CD19xCD3 T-Cell Engager, in Patients with Relapsed/Refractory (R/R) B-NHL

DC Field Value Language
dc.contributor.author김진석-
dc.date.accessioned2023-06-02T00:59:29Z-
dc.date.available2023-06-02T00:59:29Z-
dc.date.issued2022-11-
dc.identifier.issn0006-4971-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/194571-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherAmerican Society of Hematology-
dc.relation.isPartOfBLOOD-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleInterim Results of the Phase 1 Study of Tnb-486, a Novel CD19xCD3 T-Cell Engager, in Patients with Relapsed/Refractory (R/R) B-NHL-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorJing-Zhou Hou-
dc.contributor.googleauthorRyan Jacobs-
dc.contributor.googleauthorSeok-Goo Cho-
dc.contributor.googleauthorSumana Devata-
dc.contributor.googleauthorSameh Gaballa-
dc.contributor.googleauthorDok Hyun Yoon-
dc.contributor.googleauthorDon A. Stevens-
dc.contributor.googleauthorJin Seok Kim-
dc.contributor.googleauthorBen Buelow-
dc.contributor.googleauthorRanjit Nair-
dc.identifier.doi10.1182/blood-2022-166385-
dc.contributor.localIdA01017-
dc.relation.journalcodeJ00341-
dc.identifier.eissn1528-0020-
dc.identifier.urlhttps://ashpublications.org/blood/article/140/Supplement%201/1474/492758/Interim-Results-of-the-Phase-1-Study-of-Tnb-486-a-
dc.contributor.alternativeNameKim, Jin Seok-
dc.contributor.affiliatedAuthor김진석-
dc.citation.volume140-
dc.citation.numberSuppl 1-
dc.citation.startPage1474-
dc.citation.endPage1475-
dc.identifier.bibliographicCitationBLOOD, Vol.140(Suppl 1) : 1474-1475, 2022-11-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.